Patent · US Active

Disease therapy using a tolerogenic pharmaceutical preparation

US10653758B2 · kind B2 · utility

1Cited by

0References

26Claims

0Family size

Assignees

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
ETABLISSEMENT FRANCAIS DU SANG (EFS) · FR
UNIVERSITE DE FRANCHE-COMTE · FR
Centre Hospitalier Regional Et Universitaire De Brest · FR

Inventors

Sylvain Perruche · Placey, FR
Philippe SAAS · Besançon, FR
Francis Bonnefoy · Terminal 1 - Part B, FR

Key dates

Filing date	Jan 7, 2014
Grant date	May 19, 2020
Priority date	—
Expiry date	Aug 11, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/435
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein is a method for treating or preventing a pathological immune response comprising administering a supernatant obtainable from co-culture of phagocytes with apoptotic cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.